Pancreatic Cancer Research

ResearcherMasaryk Memorial Cancer InstituteNo recent work listed

Radka Lordick Obermannova

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7363-7879; OpenAlex author ID A5025931905. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 trial

Papers 1

  1. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group … Co-author DOI 10.1080/14737140.2017.1369882↗

Trials 1

  1. Determining Minimal Residual Disease Using ctDNA Deep Sequencing Principal investigator NCT07660627↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Petr Müller · 1 shared trial, 2022 · strength 0.49
  2. David Goldstein · 1 shared paper, 2017 · strength 0.07
  3. Florian Lordick · 1 shared paper, 2017 · strength 0.07
  4. Timothy Jay Price · 1 shared paper, 2017 · strength 0.07
  5. Ben J. Lawrence · 1 shared paper, 2017 · strength 0.07
  6. Eva Segelov · 1 shared paper, 2017 · strength 0.07
  7. Lorraine A. Chantrill · 1 shared paper, 2017 · strength 0.07
  8. Ian Chau · 1 shared paper, 2017 · strength 0.07
  9. Daniel Gerald Croagh · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.